Department of Epidemiology and Biostatistics, School of Public Health, Peking University, No. 38 Xueyuan Road, Haidian District, Beijing, 100191, China.
J Epidemiol Glob Health. 2023 Jun;13(2):344-360. doi: 10.1007/s44197-023-00109-0. Epub 2023 May 13.
Primary liver cancer is not only one of the most common causes of cancer deaths but also the second most common cause of premature death worldwide. Understanding the trends in incidence and mortality of primary liver cancer and its etiologies is crucial for development of effective prevention and mitigation strategies. This study aimed to quantify the trends in incidence and mortality of primary liver cancer and its etiologies at the global, regional and national levels using data from Global Burden of Disease (GBD) study.
Annual incident cases, deaths, age-standardized incidence rates (ASIRs), and age-standardized mortality rates (ASMRs) of primary liver cancer and its etiologies, including hepatitis B, hepatitis C, alcohol use, nonalcoholic steatohepatitis, and other causes, between 1990 and 2019 were collected from GBD study 2019. Percentage changes in incident cases and deaths and estimated annual percentage changes (EAPCs) in ASIRs and ASMRs of primary liver cancer and its etiologies were calculated to quantify their temporal trends. Correlations of EAPC in ASIRs and ASMRs with socio-demographic index (SDI) and universal health coverage index (UHCI) in 2019 were separately evaluated by Pearson correlation analyses.
Globally, the incident cases and deaths of primary liver cancer increased by 43.11% from 373 393 in 1990 to 534 365 in 2019 and 32.68% from 365 213 in 1990 to 484 584 in 2019, respectively. ASIR and ASMR of primary liver cancer decreased by an average of 2.23% (95% CI 1.83%, 2.63%) and 1.93% (95% CI 1.55%, 2.31%) per year between 1990 and 2019 worldwide, respectively. ASIRs and ASMRs of primary liver cancer varied between regions, with an increasing trend in ASIR (EAPC = 0.91; 95% CI 0.47, 1.35) and a stable trend in ASMR (EAPC = 0.42, 95% CI - 0.01, 0.85) of primary liver cancer in high SDI region between 1990 and 2019. Nearly half (91/204) of the countries suffered an increasing trend in ASIR of primary liver cancer and more than one-third (71/204) of the countries suffered an increasing trend in ASIRs of primary liver cancer from all etiologies between 1990 and 2019 worldwide. Positive correlations of EAPC in ASIR and ASMR of primary liver cancer with SDI and UHCI were observed in nations with SDI ≥ 0.7 or UHCI ≥ 70.
Primary liver cancer remains a major public health concern globally, with an increasing trend in the numbers of incident cases and deaths in the past three decades. We observed an increasing trend in ASIR of primary liver cancer in nearly half of the countries and an increasing trend in ASIRs of primary liver cancer by etiology in more than one-third of the countries worldwide. In line with the Sustainable Development Goals, the identification and elimination of risk factors for primary liver cancer will be required to achieve a sustained reduction in liver cancer burden.
原发性肝癌不仅是癌症死亡的最常见原因之一,也是全球范围内导致过早死亡的第二大常见原因。了解原发性肝癌的发病率和死亡率趋势及其病因,对于制定有效的预防和缓解策略至关重要。本研究旨在利用全球疾病负担(GBD)研究的数据,定量评估全球、区域和国家层面原发性肝癌及其病因(包括乙型肝炎、丙型肝炎、饮酒、非酒精性脂肪性肝炎和其他原因)的发病率和死亡率趋势。
从 GBD 2019 研究中收集了 1990 年至 2019 年期间原发性肝癌及其病因(包括乙型肝炎、丙型肝炎、饮酒、非酒精性脂肪性肝炎和其他原因)的发病例数、死亡例数、年龄标准化发病率(ASIR)和年龄标准化死亡率(ASMR)。计算原发性肝癌及其病因的发病例数和死亡例数的变化百分比以及 ASIR 和 ASMR 的估计年变化百分比(EAPC),以量化其时间趋势。分别通过 Pearson 相关分析评估 2019 年 ASIR 和 ASMR 与社会人口指数(SDI)和全民健康覆盖指数(UHCI)的 EAPC 之间的相关性。
全球范围内,原发性肝癌的发病例数和死亡例数分别从 1990 年的 373393 例增加到 2019 年的 534365 例,增加了 43.11%,从 1990 年的 365213 例增加到 2019 年的 484584 例,增加了 32.68%。1990 年至 2019 年期间,全球原发性肝癌的 ASIR 和 ASMR 平均每年分别下降 2.23%(95%CI 1.83%,2.63%)和 1.93%(95%CI 1.55%,2.31%)。原发性肝癌的 ASIR 和 ASMR 在各区域之间存在差异,1990 年至 2019 年期间,高 SDI 地区的原发性肝癌 ASIR 呈上升趋势(EAPC=0.91;95%CI 0.47,1.35),ASMR 呈稳定趋势(EAPC=0.42;95%CI -0.01,0.85)。1990 年至 2019 年期间,全球近一半(91/204)的国家原发性肝癌 ASIR 呈上升趋势,超过三分之一(71/204)的国家原发性肝癌所有病因的 ASIR 呈上升趋势。在 SDI≥0.7 或 UHCI≥70 的国家中,观察到原发性肝癌 ASIR 和 ASMR 的 EAPC 与 SDI 和 UHCI 呈正相关。
原发性肝癌仍然是全球主要的公共卫生问题,在过去三十年中,发病例数和死亡例数呈上升趋势。我们观察到,全球近一半的国家原发性肝癌的 ASIR 呈上升趋势,超过三分之一的国家原发性肝癌所有病因的 ASIR 呈上升趋势。为了持续降低肝癌负担,需要识别和消除原发性肝癌的风险因素。